Loading...
Loading...
Among the 2 tracked institutional investors we monitor, MDCX (MEDICUS PHARMA LTD) is held with a combined value of $25.30K across 55,118 shares. The largest holder is BlackRock, Inc. with a position worth $17.12K (0.00% of their portfolio). CITADEL ADVISORS LLC opened a new position in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$25.30K
Total Shares Held
55,118
Institutional Holders
2
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $17.12K | 0.00% | +8.7% |
| 2 | CITADEL ADVISORS LLC | $8.18K | 0.00% | New |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of MDCX with a position worth $17.12K, representing 0.00% of their portfolio. In total, 2 institutional investors hold MDCX with a combined value of $25.30K.
In the most recent quarter, 1 fund opened a new position in MDCX. Additionally, 1 increased their holdings.
Institutional investors hold $25.30K worth of MDCX stock across 2 positions. The largest institutional holder is BlackRock, Inc. with $17.12K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For MDCX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their MDCX positions.